Pharmafile Logo
Pharmafocus logo
Advanced Search

Weak dollar contains Sanofi growth

October 31, 2003

The weakness of the US dollar more than halved Sanofi-Synthelabo's earnings in the first half of this year, but disguised …

News

Heart failure guidelines recommend ACE inhibitors

October 31, 2003

ACE inhibitors have been recommended as first line treatment for chronic heart failure as part of a comprehensive set of …

News

Media training company launched

October 31, 2003

A new training agency specialising in preparing pharmaceutical spokespeople to deal with modern media techniques has been launched.Asparagus Media, set …

News

Industry could gain access to yellow card data

October 31, 2003

The pharmaceutical industry could be granted access to data from the UK's Yellow Card adverse effect warning system to assist …

News

Celebrex to gain orphan drug indication

October 31, 2003

Pfizer's blockbuster arthritis drug Celebrex is set to gain a European orphan drug licence for the treatment of a rare …

News

Challenging second quarter for big pharma

October 31, 2003

Generic competition and wholesaler de-stocking are among the problems besetting two of the industry's biggest hitters, GlaxoSmithKline and AstraZeneca.Deutsche Bank …

News

NICE suspends breast cancer appraisal to await data

October 31, 2003

News

NHS leaders pour scorn on star ratings

October 31, 2003

New star ratings for all NHS trusts have been attacked by leaders in primary and secondary care, who say they …

News

PCTs to hold balance of power in community pharmacy

October 31, 2003

Pharmacy leaders have welcomed plans to protect local pharmacies from greater competition, but say crucial detail must now be agreed …

News

Breakthrough in consultant contract talks

October 31, 2003

Doctors' leaders have declared a breakthrough in the long-running and bitter dispute over the new consultants' contract.The halving of the …

News

Seroxat safety review widens

October 31, 2003

News

GlaxoSmithKline announce Indian partnership

October 29, 2003

News

PR heavyweights launch new agency

October 29, 2003

Former managing directors of Shire Health London and Cohn & Wolfe Healthcare have joined forces to launch a new independent, …

News

New R&D chief as Merck files Erbitux

October 29, 2003

German pharmaceutical Merck KgaA has appointed a new head of clinical research and development following a major R&D re-organisation. Dr …

News

Liver test takes shine off Exanta

October 29, 2003

AstraZeneca has admitted that patients on its new anti-clotting drug Exanta will need liver tests, denting the drug's profile as …

News

US approval for breakthrough diabetes device

October 29, 2003

The first integrated glucose meter and insulin pump has been approved by the FDA, bringing the goal of an 'artificial …

News

Pharmacy reform must look at ‘bigger picture’

October 29, 2003

MPs have criticised a report recommending opening up community pharmacy to greater competition, saying its value had been misunderstood.David Hinchcliffe, …

News

Generic threat to Lilly’s biggest seller

October 29, 2003

A court challenge to Eli Lilly's patent on its number one drug Zyprexa could spell serious trouble for the company, …

News

AstraZeneca buoyed by Crestor clearance

October 29, 2003

AstraZeneca's new statin drug has received unanimous approval by a key FDA panel, and now looks set to be launched …

News

CROs continue to extend global reach

October 29, 2003

Contract research organisations from Europe and the US are continuing to expand their operations in order to meet the pharmaceutical …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026